Anti Aging Medicine And Research India Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 22-12-2024
- Paid Up Capital ₹ 0.10 M
as on 22-12-2024
- Company Age 16 Year, 10 Months
- Last Filing with ROC 31 Mar 2021
- Revenue %
(FY 2019)
- Profit 88.03%
(FY 2019)
- Ebitda 91.20%
(FY 2019)
- Net Worth -241.71%
(FY 2019)
- Total Assets -1.41%
(FY 2019)
About Anti Aging Medicine And Research India
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Deepak Chaturvedi and Anoop Chaturvedi serve as directors at the Company.
- CIN/LLPIN
U24233MH2008NPL179330
- Company No.
179330
- Company Classification
Private Not For Profit Company
- Incorporation Date
22 Feb 2008
- Date of AGM
29 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Anti Aging Medicine And Research India?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Deepak Chaturvedi  | Director | 18-Mar-2008 | Current |
| Anoop Chaturvedi | Director | 22-Feb-2008 | Current |
Financial Performance of Anti Aging Medicine And Research India.
Anti Aging Medicine And Research India, for the financial year ended 2019, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 88.03% increase in profit. The company's net worth observed a substantial decline by a decrease of 241.71%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Anti Aging Medicine And Research India?
In 2017, Anti Aging Medicine And Research India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Vishwanjan Business Innovations Private LimitedActive 16 years 10 monthsDeepak Chaturvedi is a mutual person
- Aptomed Medicines India Private LimitedActive 16 years 10 months
Deepak Chaturvedi is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Anti Aging Medicine And Research India?
Unlock and access historical data on people associated with Anti Aging Medicine And Research India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Anti Aging Medicine And Research India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Anti Aging Medicine And Research India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
